BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31509841)

  • 1. Cribriform-Morular Variant of Papillary Thyroid Carcinoma Shows High Ki-67 Labeling Indices, despite Its Excellent Prognosis.
    Hirokawa M; Matsuda K; Kudo T; Higuchi M; Suzuki A; Takada N; Nakashima M; Miyauchi A
    Pathobiology; 2019; 86(5-6):248-253. PubMed ID: 31509841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive cribriform-morular variant of papillary thyroid carcinoma: Report of an unusual case with pulmonary metastasis displaying poorly differentiated features.
    Tsuji H; Yasuoka H; Nakamura Y; Hirokawa M; Hiroshima T; Sakamaki Y; Miyauchi A; Tsujimoto M
    Pathol Int; 2018 Dec; 68(12):700-705. PubMed ID: 30376202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation.
    Kwon MJ; Rho YS; Jeong JC; Shin HS; Lee JS; Cho SJ; Nam ES
    Hum Pathol; 2015 Aug; 46(8):1180-8. PubMed ID: 26054797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
    Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
    [No Abstract]   [Full Text] [Related]  

  • 5. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer.
    Lam AK; Saremi N
    Endocr Relat Cancer; 2017 Apr; 24(4):R109-R121. PubMed ID: 28314770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEF-1 is a Sensitive Marker of Cribriform Morular Variant of Papillary Thyroid Carcinoma.
    Mohindra S; Sakr H; Sturgis C; Chute DJ
    Head Neck Pathol; 2018 Dec; 12(4):455-462. PubMed ID: 29243023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of cribriform morular variant of papillary thyroid carcinoma in post-Chernobyl affected region.
    Lam AK; Fridman M
    Hum Pathol; 2018 Apr; 74():170-177. PubMed ID: 29320754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration.
    Boonyaarunnate T; Olson MT; Bishop JA; Yang GC; Ali SZ
    Acta Cytol; 2013; 57(2):127-33. PubMed ID: 23406819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cribriform-morular variant of papillary thyroid carcinoma.
    Pradhan D; Sharma A; Mohanty SK
    Pathol Res Pract; 2015 Oct; 211(10):712-6. PubMed ID: 26293799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature.
    Aydemirli MD; van der Tuin K; Hes FJ; van den Ouweland AMW; van Wezel T; Kapiteijn E; Morreau H
    Fam Cancer; 2020 Jan; 19(1):15-21. PubMed ID: 31598872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of the recurrent surgery for cribriform-morular variant of papillary thyroid carcinoma.
    Enomoto K; Tamagawa S; Kumashiro N; Warigaya K; Takeda S; Gunduz M; Murata SI; Hotomi M
    Int J Surg Case Rep; 2020; 66():385-389. PubMed ID: 31954984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients.
    Ito Y; Miyauchi A; Ishikawa H; Hirokawa M; Kudo T; Tomoda C; Miya A
    Endocr J; 2011; 58(8):685-9. PubMed ID: 21670544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP.
    Levy RA; Hui VW; Sood R; Fish S; Markowitz AJ; Wong RJ; Guillem JG
    Fam Cancer; 2014 Dec; 13(4):547-51. PubMed ID: 24934245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway.
    Cameselle-Teijeiro JM; Peteiro-González D; Caneiro-Gómez J; Sánchez-Ares M; Abdulkader I; Eloy C; Melo M; Amendoeira I; Soares P; Sobrinho-Simões M
    Mod Pathol; 2018 Aug; 31(8):1168-1179. PubMed ID: 29785019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cribriform morular variant of papillary thyroid carcinoma: Cytomorphology, differential diagnosis and diagnostic implications in patients with adenomatous polyposis coli.
    Priyani AA; Opatha ST; Gunathilake NW; Lokuhetty MD
    J Cytol; 2016; 33(4):235-238. PubMed ID: 28028343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary metastasis of cribriform-morular variant of thyroid carcinoma mimicking primary adenocarcinoma of the lung: A potential pitfall.
    Laforga JB; Pedro T; Gasent JM
    Diagn Cytopathol; 2020 Jan; 48(1):78-81. PubMed ID: 31483569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cribriform-morular variant of papillary thyroid carcinoma--cytological and immunocytochemical findings of 18 cases.
    Hirokawa M; Maekawa M; Kuma S; Miyauchi A
    Diagn Cytopathol; 2010 Dec; 38(12):890-6. PubMed ID: 20091902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.
    Matsuse M; Yabuta T; Saenko V; Hirokawa M; Nishihara E; Suzuki K; Yamashita S; Miyauchi A; Mitsutake N
    Sci Rep; 2017 Feb; 7():41752. PubMed ID: 28150740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
    Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
    Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cribriform-morular variant of papillary thyroid carcinoma at pediatric age - case report and review of the literature.
    Brehar AC; Terzea DC; Ioachim DL; Procopiuc C; Brehar FM; Bulgăr AC; Ghemigian MV; Dumitrache C
    Rom J Morphol Embryol; 2016; 57(2):531-7. PubMed ID: 27516030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.